_id
69105310ccc777a4e85d5500
Ticker
COO
Name
The Cooper Companies, Inc
Exchange
NASDAQ
Address
6101 Bollinger Canyon Road, San Ramon, CA, United States, 94583
Country
USA
Sector
Healthcare
Industry
Medical Instruments & Supplies
Currency
USD
Website
https://www.coopercos.com
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia; and spherical lense, including lenses that correct near and farsightedness in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including paragard contraceptive intrauterine devices; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Last Close
82.08
Volume
1398747
Current Price
81.53
Change
-0.6700779727095483
Last Updated
2025-11-29T11:45:07.083Z
Image
data:image/webp;base64,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
Ipo Date
1983-12-30T00:00:00.000Z
Market Cap
15548010496
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9851615384615386
Sentiment Sources
26
Rating
4.0526
Target Price
83
Strong Buy
9
Buy
2
Hold
8
Sell
0
Strong Sell
0
Current Quarter
2025-07-31
Revenue
1060300000
Cost Of Revenue
368300000
Gross Profit
692000000
Operating Expenses
516300000
Operating Income
175700000
Interest Expense
25400000
Pretax Income
151900000
Net Income
98300000
Eps
0.4900299102691924
Dividends Per Share
-
Shares Outstanding
198808921
Income Tax Expense
53600000
EBITDA
272700000
Operating Margin
16.57078185419221
Total Other Income Expense Net
-23800000
Cash
124900000
Short Term Investments
-
Receivables
792300000
Inventories
881000000
Total Current Assets
2137800000
Property Plant Equipment
1988700000
Total Assets
12376700000
Payables
255900000
Short Term Debt
47800000
Long Term Debt
2429500000
Total Liabilities
4023700000
Equity
8353000000
Depreciation
95400000
Change In Working Capital
-18500000
Cash From Operations
261400000
Capital Expenditures
96900000
Cash From Investing
-98100000
Cash From Financing
-156300000
Net Change In Cash
8700000
PE
38.201
PB
1.9579693523285047
ROE
1.1768226984317012
ROA
0.7942343274055281
FCF
164500000
Fcf Percent
0.15514477034801472
Piotroski FScore
4
Health Score
67
Deep Value Investing Score
5.5
Defensive Investing Score
8
Dividend Investing Score
3
Economic Moat Investing Score
7.3
Garp Investing Score
5
Growth Investing Score
4.5
Momentum Investing Score
4.5
Net Net Investing Score
2.5
Quality Investing Score
6.5
Value Investing Score
5.5
Quarters > 0 > quarter
2025-07-31
Quarters > 0 > income Statement > revenue
1060300000
Quarters > 0 > income Statement > cost Of Revenue
368300000
Quarters > 0 > income Statement > gross Profit
692000000
Quarters > 0 > income Statement > operating Expenses
516300000
Quarters > 0 > income Statement > operating Income
175700000
Quarters > 0 > income Statement > interest Expense
25400000
Quarters > 0 > income Statement > pretax Income
151900000
Quarters > 0 > income Statement > net Income
98300000
Quarters > 0 > income Statement > eps
0.4900299102691924
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
200600000
Quarters > 0 > income Statement > income Tax Expense
53600000
Quarters > 0 > income Statement > EBITDA
272700000
Quarters > 0 > income Statement > operating Margin
16.57078185419221
Quarters > 0 > income Statement > total Other Income Expense Net
-23800000
Quarters > 0 > balance Sheet > cash
124900000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
792300000
Quarters > 0 > balance Sheet > inventories
881000000
Quarters > 0 > balance Sheet > total Current Assets
2137800000
Quarters > 0 > balance Sheet > property Plant Equipment
1988700000
Quarters > 0 > balance Sheet > total Assets
12376700000
Quarters > 0 > balance Sheet > payables
255900000
Quarters > 0 > balance Sheet > short Term Debt
47800000
Quarters > 0 > balance Sheet > long Term Debt
2429500000
Quarters > 0 > balance Sheet > total Liabilities
4023700000
Quarters > 0 > balance Sheet > equity
8353000000
Quarters > 0 > cash Flow > net Income
98300000
Quarters > 0 > cash Flow > depreciation
95400000
Quarters > 0 > cash Flow > change In Working Capital
-18500000
Quarters > 0 > cash Flow > cash From Operations
261400000
Quarters > 0 > cash Flow > capital Expenditures
96900000
Quarters > 0 > cash Flow > cash From Investing
-98100000
Quarters > 0 > cash Flow > cash From Financing
-156300000
Quarters > 0 > cash Flow > net Change In Cash
8700000
Quarters > 0 > ratios > PE
0.4900299102691924
Quarters > 0 > ratios > PB
1.9579693523285047
Quarters > 0 > ratios > ROE
1.1768226984317012
Quarters > 0 > ratios > ROA
0.7942343274055281
Quarters > 0 > ratios > FCF
164500000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.15514477034801472
Quarters > 0 > health Score
67
Quarters > 1 > quarter
2025-04-30
Quarters > 1 > income Statement > revenue
1002300000
Quarters > 1 > income Statement > cost Of Revenue
323200000
Quarters > 1 > income Statement > gross Profit
679100000
Quarters > 1 > income Statement > operating Expenses
494300000
Quarters > 1 > income Statement > operating Income
184800000
Quarters > 1 > income Statement > interest Expense
33300000
Quarters > 1 > income Statement > pretax Income
144500000
Quarters > 1 > income Statement > net Income
87700000
Quarters > 1 > income Statement > eps
0.4369706028898854
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
200700000
Quarters > 1 > income Statement > income Tax Expense
56800000
Quarters > 1 > income Statement > EBITDA
261300000
Quarters > 1 > income Statement > operating Margin
18.4375935348698
Quarters > 1 > income Statement > total Other Income Expense Net
-40300000
Quarters > 1 > balance Sheet > cash
116200000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
780900000
Quarters > 1 > balance Sheet > inventories
880300000
Quarters > 1 > balance Sheet > total Current Assets
2125700000
Quarters > 1 > balance Sheet > property Plant Equipment
1928500000
Quarters > 1 > balance Sheet > total Assets
12413600000
Quarters > 1 > balance Sheet > payables
244200000
Quarters > 1 > balance Sheet > short Term Debt
59800000
Quarters > 1 > balance Sheet > long Term Debt
2523600000
Quarters > 1 > balance Sheet > total Liabilities
4125500000
Quarters > 1 > balance Sheet > equity
8287900000
Quarters > 1 > cash Flow > net Income
87700000
Quarters > 1 > cash Flow > depreciation
92600000
Quarters > 1 > cash Flow > change In Working Capital
-165600000
Quarters > 1 > cash Flow > cash From Operations
96200000
Quarters > 1 > cash Flow > capital Expenditures
78100000
Quarters > 1 > cash Flow > cash From Investing
-79200000
Quarters > 1 > cash Flow > cash From Financing
-8600000
Quarters > 1 > cash Flow > net Change In Cash
15200000
Quarters > 1 > ratios > PE
0.4369706028898854
Quarters > 1 > ratios > PB
1.9743325812328816
Quarters > 1 > ratios > ROE
1.0581691381411455
Quarters > 1 > ratios > ROA
0.7064832119610749
Quarters > 1 > ratios > FCF
18100000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.018058465529282648
Quarters > 1 > health Score
53
Quarters > 2 > quarter
2025-01-31
Quarters > 2 > income Statement > revenue
964700000
Quarters > 2 > income Statement > cost Of Revenue
304500000
Quarters > 2 > income Statement > gross Profit
660200000
Quarters > 2 > income Statement > operating Expenses
478200000
Quarters > 2 > income Statement > operating Income
182000000
Quarters > 2 > income Statement > interest Expense
26000000
Quarters > 2 > income Statement > pretax Income
153300000
Quarters > 2 > income Statement > net Income
104300000
Quarters > 2 > income Statement > eps
0.518389662027833
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
201200000
Quarters > 2 > income Statement > income Tax Expense
49000000
Quarters > 2 > income Statement > EBITDA
270300000
Quarters > 2 > income Statement > operating Margin
18.86596869493107
Quarters > 2 > income Statement > total Other Income Expense Net
-28700000
Quarters > 2 > balance Sheet > cash
100900000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
716400000
Quarters > 2 > balance Sheet > inventories
842900000
Quarters > 2 > balance Sheet > total Current Assets
1987000000
Quarters > 2 > balance Sheet > property Plant Equipment
1864700000
Quarters > 2 > balance Sheet > total Assets
12222200000
Quarters > 2 > balance Sheet > payables
201500000
Quarters > 2 > balance Sheet > short Term Debt
48700000
Quarters > 2 > balance Sheet > long Term Debt
2489100000
Quarters > 2 > balance Sheet > total Liabilities
4094700000
Quarters > 2 > balance Sheet > equity
8127300000
Quarters > 2 > cash Flow > net Income
104300000
Quarters > 2 > cash Flow > depreciation
91000000
Quarters > 2 > cash Flow > change In Working Capital
-75600000
Quarters > 2 > cash Flow > cash From Operations
190600000
Quarters > 2 > cash Flow > capital Expenditures
89400000
Quarters > 2 > cash Flow > cash From Investing
-96800000
Quarters > 2 > cash Flow > cash From Financing
-96600000
Quarters > 2 > cash Flow > net Change In Cash
-6700000
Quarters > 2 > ratios > PE
0.518389662027833
Quarters > 2 > ratios > PB
2.018362309746164
Quarters > 2 > ratios > ROE
1.283329026860089
Quarters > 2 > ratios > ROA
0.8533651879367052
Quarters > 2 > ratios > FCF
101200000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.10490307867730901
Quarters > 2 > health Score
58
Quarters > 3 > quarter
2024-10-31
Quarters > 3 > income Statement > revenue
1018400000
Quarters > 3 > income Statement > cost Of Revenue
340700000
Quarters > 3 > income Statement > gross Profit
677700000
Quarters > 3 > income Statement > operating Expenses
479300000
Quarters > 3 > income Statement > operating Income
198400000
Quarters > 3 > income Statement > interest Expense
27000000
Quarters > 3 > income Statement > pretax Income
168600000
Quarters > 3 > income Statement > net Income
117500000
Quarters > 3 > income Statement > eps
0.5842864246643461
Quarters > 3 > income Statement > dividends Per Share
0
Quarters > 3 > income Statement > shares Outstanding
201100000
Quarters > 3 > income Statement > income Tax Expense
51100000
Quarters > 3 > income Statement > EBITDA
286600000
Quarters > 3 > income Statement > operating Margin
19.4815396700707
Quarters > 3 > income Statement > total Other Income Expense Net
-29800000
Quarters > 3 > balance Sheet > cash
107600000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
717000000
Quarters > 3 > balance Sheet > inventories
802700000
Quarters > 3 > balance Sheet > total Current Assets
1951500000
Quarters > 3 > balance Sheet > property Plant Equipment
1863400000
Quarters > 3 > balance Sheet > total Assets
12315200000
Quarters > 3 > balance Sheet > payables
260500000
Quarters > 3 > balance Sheet > short Term Debt
33300000
Quarters > 3 > balance Sheet > long Term Debt
2548000000
Quarters > 3 > balance Sheet > total Liabilities
4231600000
Quarters > 3 > balance Sheet > equity
8083400000
Quarters > 3 > cash Flow > net Income
117500000
Quarters > 3 > cash Flow > depreciation
91000000
Quarters > 3 > cash Flow > change In Working Capital
-31200000
Quarters > 3 > cash Flow > cash From Operations
268100000
Quarters > 3 > cash Flow > capital Expenditures
140000000
Quarters > 3 > cash Flow > cash From Investing
-241600000
Quarters > 3 > cash Flow > cash From Financing
-28400000
Quarters > 3 > cash Flow > net Change In Cash
-2100000
Quarters > 3 > ratios > PE
0.5842864246643461
Quarters > 3 > ratios > PB
2.0283151891530795
Quarters > 3 > ratios > ROE
1.4535962589999256
Quarters > 3 > ratios > ROA
0.9541054956476549
Quarters > 3 > ratios > FCF
128100000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.12578554595443833
Quarters > 3 > health Score
60
Valuation > metrics > PE
38.201
Valuation > metrics > PB
1.9579693523285047
Valuation > final Score
64.1588
Valuation > verdict
26.4% Overvalued
Profitability > metrics > ROE
1.1768226984317012
Profitability > metrics > ROA
4.5981850500514545
Profitability > metrics > Net Margin
0.09270961048759785
Profitability > final Score
30
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.48170717107626004
Risk > metrics > Interest Coverage
6.917322834645669
Risk > final Score
88
Risk > verdict
Low
Liquidity > metrics > Current Ratio
7.039183404675667
Liquidity > metrics > Quick Ratio
4.13829436944353
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
100
Prev Valuations > 1
100
Prev Valuations > 2
100
Prev Profitabilities > 0
28
Prev Profitabilities > 1
35
Prev Profitabilities > 2
38
Prev Risks > 0
82
Prev Risks > 1
76
Prev Risks > 2
77
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-16T22:31:59.796Z
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia; and spherical lense, including lenses that correct near and farsightedness in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including paragard contraceptive intrauterine devices; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ADiscipline and Rules-Based Execution in COO Response news.stocktradersdaily.com
Read more →Entravision Communications (NYSE:EVC) COO Sells $70,930.08 in Stock MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-07-31)
Rating:
BUY
Target Price:
$83
Analyst Picks
Strong Buy
9
Buy
2
Hold
8
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-07-31)
Health Score
Price to Earnings Ratio (P/E)
-
Low
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Medium
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 89.65% of the total shares of The Cooper Companies, Inc
1.
Vanguard Group Inc(12.2%)
since
2025/06/30
2.
BlackRock Inc(7.7728%)
since
2025/06/30
3.
State Street Corp(4.3558%)
since
2025/06/30
4.
Capital World Investors(4.2213%)
since
2025/06/30
5.
Kayne Anderson Rudnick Investment Management LLC(3.9509%)
since
2025/06/30
6.
T. Rowe Price Investment Management,Inc.(3.7119%)
since
2025/06/30
7.
T. Rowe Price Associates, Inc.(3.2933%)
since
2025/06/30
8.
Vanguard Total Stock Mkt Idx Inv(3.1659%)
since
2025/07/31
9.
Geode Capital Management, LLC(2.6184%)
since
2025/06/30
10.
Neuberger Berman Group LLC(2.5472%)
since
2025/06/30
11.
Vanguard 500 Index Investor(2.4908%)
since
2025/07/31
12.
Amvescap Plc.(2.3258%)
since
2025/06/30
13.
T. Rowe Price Mid-Cap Growth(2.1589%)
since
2025/07/31
14.
Goldman Sachs Group Inc(1.9418%)
since
2025/06/30
15.
AllianceBernstein L.P.(1.9038%)
since
2025/06/30
16.
HHG PLC(1.8713%)
since
2025/06/30
17.
T. Rowe Price US Mid-Cap Growth Equity(1.7585%)
since
2025/06/30
18.
Ameriprise Financial Inc(1.7044%)
since
2025/06/30
19.
Sustainable Growth Advisers, LP(1.7027%)
since
2025/06/30
20.
Victory Capital Management Inc.(1.6966%)
since
2025/06/30
21.
UBS Asset Mgmt Americas Inc(1.5116%)
since
2025/06/30
22.
JPMorgan Chase & Co(1.3557%)
since
2025/06/30
23.
Bridge Builder Large Cap Growth(1.301%)
since
2025/08/31
24.
Fidelity 500 Index(1.2751%)
since
2025/07/31
25.
Vanguard Small Cap Index(1.2209%)
since
2025/07/31
26.
Victory Sycamore Established Value R(1.2112%)
since
2025/06/30
27.
iShares Core S&P 500 ETF(1.2104%)
since
2025/08/31
28.
SPDR® S&P 500® ETF(1.2079%)
since
2025/08/31
29.
Capital Group New Perspective Comp(1.1782%)
since
2025/06/30
30.
American Funds New Perspective A(1.1782%)
since
2025/06/30
31.
Vanguard Mid Cap Index Institutional(1.122%)
since
2025/07/31
32.
Champlain Investment Partners, LLC(1.0416%)
since
2025/06/30
33.
Holocene Advisors, LP(1.0295%)
since
2025/06/30
34.
Champlain Mid Cap Fund, LLC(1.0097%)
since
2025/08/31
35.
Invesco S&P 500® Equal Weight ETF(0.9964%)
since
2025/08/29
36.
Findlay Park American I USD Dist(0.9134%)
since
2025/06/30
37.
T. Rowe Price US Mid-Cap Value Equity(0.9058%)
since
2025/06/30
38.
T. Rowe Price Mid-Cap Value(0.9045%)
since
2025/07/31
39.
Janus Henderson Enterprise D(0.8445%)
since
2025/06/30
40.
Janus Inst Mid Cap Growth CF(0.8445%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-07-31)
(Last Updated 2025-07-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-07-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-07-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.